Bioreactors Market Scope And Analysis

Report Code : TIPHE100000880
Category : Life Sciences

Status : Published
No. of Pages : 176

Buy Now

Bioreactors Market Analysis, Size, and Growth (2024-2031)

Buy Now

Bioreactors Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 3,643.00 Million
Market Size by 2030	US$ 6,570.76 Million
Global CAGR (2022-2030)	7.65%
Historical Data	2020-2021
Forecast period	2022-2030
Segments Covered	By Scale Lab-Scale Production Pilot-Scale Production Full-Scale Production By Application Microbial Application Cell Culture Application By Technology Fed-Batch Bioreactors and Perfusion Bioreactors By End User Biopharma Manufacturers Research and Development Organizations Contract Manufacturing Organization
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Sartorius AG PBS Biotech Merck KGaA Cellexus International Ltd General Electric Co Thermo Fisher Scientific Inc bbi biotech GmbH Pall Corp Applikon Biotechnology BV Solaris Biotechnology SRL

Bioreactors Market News and Recent Developments

The bioreactors market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the bioreactors market are listed below:

Getinge is extending its bioreactor offering by introducing the Single-Use Production Reactor (SUPR) system, which initially is available in 50-liter and 250-liter sizes. Based on the same proven platform as Getinge’s smaller bioreactors, the SUPR system helps operators to bring life-saving medicines faster to market, aiming to improve people’s quality of life. (Source: Getinge, Press Release, 2024)
Global technology and software leader Emerson has collaborated with Sartorius, a leading international biopharmaceutical company, to natively integrate Sartorius’s Biostat STR Generation 3 family of bioreactors with Emerson’s DeltaV distributed control system (DCS). The Biostat STR Generation 3 for Emerson’s DeltaV, a variant of the Biostat STR Generation 3 family, is a pre-engineered solution that delivers intuitive connectivity for accelerating and simplifying the process of bringing therapies that improve patient quality-of-life to market. (Source: Emerson Electric Co., Press Release, 2023)

Bioreactors Market Report Coverage and Deliverables

The “Bioreactors Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Bioreactors market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Bioreactors market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Bioreactors market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the bioreactors market
Detailed company profiles